For help on how to get the results you want, see our search tips.
257 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Human medicine European public assessment report (EPAR): Sebivo (updated)
telbivudine, Hepatitis B, Chronic
Date of authorisation: 24/04/2007, Revision: 20, Withdrawn, Last updated: 14/01/2021 -
List item
Human medicine European public assessment report (EPAR): Panretin (updated)
alitretinoin, Sarcoma, Kaposi
Date of authorisation: 11/10/2000, Revision: 17, Withdrawn, Last updated: 11/01/2021 -
List item
Human medicine European public assessment report (EPAR): Alpivab
Peramivir, Influenza, Human
Date of authorisation: 13/04/2018,, Revision: 2, Withdrawn, Last updated: 09/12/2020
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 10/06/2010,, Revision: 10, Withdrawn, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Vepacel
Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 17/02/2012, Revision: 9, Withdrawn, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Zerit
stavudine, HIV Infections
Date of authorisation: 08/05/1996, Revision: 31, Withdrawn, Last updated: 13/10/2020 -
List item
Human medicine European public assessment report (EPAR): Qtrilmet
metformin hydrochloride, Saxagliptin, dapagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2019, Revision: 2, Withdrawn, Last updated: 09/10/2020 -
List item
Human medicine European public assessment report (EPAR): Zurampic
lesinurad, Hyperuricemia
Date of authorisation: 18/02/2016,, Revision: 4, Withdrawn, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Picato
Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012,,
, Revision: 10, Withdrawn, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Kolbam
cholic acid, Metabolism, Inborn Errors
Date of authorisation: 20/11/2015,, Revision: 14, Withdrawn, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Fertavid
follitropin beta, Infertility, Hypogonadism
Date of authorisation: 19/03/2009, Revision: 12, Withdrawn, Last updated: 23/06/2020 -
List item
Human medicine European public assessment report (EPAR): Helixate NexGen
octocog alfa, Hemophilia A
Date of authorisation: 04/08/2000, Revision: 31, Withdrawn, Last updated: 02/06/2020 -
List item
Human medicine European public assessment report (EPAR): Osseor
strontium ranelate, Osteoporosis, Postmenopausal
Date of authorisation: 20/09/2004, Revision: 19, Withdrawn, Last updated: 19/05/2020 -
List item
Human medicine European public assessment report (EPAR): Protelos
strontium ranelate, Osteoporosis, Postmenopausal
Date of authorisation: 20/09/2004, Revision: 19, Withdrawn, Last updated: 15/05/2020 -
List item
Human medicine European public assessment report (EPAR): Kromeya
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 02/04/2019,,
, Revision: 4, Withdrawn, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Xiapex
collagenase Clostridium histolyticum, Dupuytren Contracture
Date of authorisation: 28/02/2011, Revision: 20, Withdrawn, Last updated: 02/03/2020 -
List item
Human medicine European public assessment report (EPAR): Varuby
rolapitant, Vomiting, Nausea, Cancer
Date of authorisation: 19/04/2017,, Revision: 3, Withdrawn, Last updated: 02/03/2020
-
List item
Human medicine European public assessment report (EPAR): Lifmior
etanercept, Arthritis, Psoriatic, Spondylitis, Ankylosing, Psoriasis
Date of authorisation: 13/02/2017, Revision: 8, Withdrawn, Last updated: 20/02/2020 -
List item
Human medicine European public assessment report (EPAR): Iblias
octocog alfa, Hemophilia A
Date of authorisation: 18/02/2016,, Revision: 4, Withdrawn, Last updated: 18/02/2020
-
List item
Human medicine European public assessment report (EPAR): Nonafact
human coagulation factor IX, Hemophilia B
Date of authorisation: 03/07/2001, Revision: 9, Withdrawn, Last updated: 18/02/2020 -
List item
Human medicine European public assessment report (EPAR): Zalmoxis
Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2), Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
Date of authorisation: 18/08/2016,, Revision: 1, Withdrawn, Last updated: 14/02/2020
-
List item
Human medicine European public assessment report (EPAR): Fexeric
ferric citrate coordination complex, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 23/09/2015,, Revision: 2, Withdrawn, Last updated: 04/02/2020
-
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Thorinane
enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 14/09/2016,,
, Revision: 2, Withdrawn, Last updated: 24/10/2019
-
List item
Human medicine European public assessment report (EPAR): Imatinib medac
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dermatofibrosarcoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myelodysplastic-Myeloproliferative Diseases, Hypereosinophilic Syndrome
Date of authorisation: 25/09/2013,, Revision: 5, Withdrawn, Last updated: 16/10/2019